Deal to acquire Covis is expected to expand Azurity’s portfolio across multiple complex dosage forms and key therapeutics ...

A panel discussion at the Global Life Science Partnering and Investor Conference discusses various strategies and trends in ...

New real-world and implementation study data highlight the efficacy of ViiV’s long-acting injectables for HIV prevention and ...

CordenPharma, a CDMO focused on peptides and peptide-based therapeutics, announced a partnership with Viking Therapeutics.

In a perfect world, every emerging biopharma company would have a clear short- and long-term vision leading up to launch.

John Arena is interim president of global pharma services at Cencora, managing a team that offers a broad range of solutions ...

Auguston kicked off an animated session titled “The People Factor” by outlining all the ways in which the CEO role in ...

A Harvard Business School Healthcare Alumni Association Q&A with Elaina Shekhter, EPAM’s Chief Marketing & Strategy Officer.

EVERSANA’s chief digital officer discusses recent developments in the pharma industry that are impacting its relationship ...

Traditional approaches to benchmarking brand performance have struggled to keep pace with industry dynamics. While individual ...

Partnership includes the development of combination products, including a fixed-dose combination of petrelintide and Roche’s dual GLP-1/GIP receptor agonist, CT-388, for weight management.

March is Colorectal Cancer Awareness Month, and the health plan hopes to improve survival rates with early screenings.